Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02587403 · ClinicalTrials.gov registry record · NA

A Comparison of Fortiva and Strattice Tissue Matrices in Complex, Ventral Hernia Repair

A NA study of Ventral Hernia, sponsored by RTI Surgical.

Completed
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT02587403 is a NA study of Ventral Hernia that has completed, run by RTI Surgical. The registered enrollment target is 120 participants, below the 136-participant average among 18 other Ventral Hernia trials with a reported enrollment target (12% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02587403, a NA study of Ventral Hernia, has completed, sponsored by RTI Surgical.

COMPLETED
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to compare the effectiveness of Fortiva Porcine Dermis versus Strattice Reconstructive Tissue Matrix for the underlay reinforcement of complex ventral hernia repair and assess post-operative complication rates, long term hernia recurrence rates.

Conditions Studied

Interventions

  • DEVICE Fortiva™ Porcine Dermis
  • DEVICE Strattice™ Reconstructive Tissue Matrix

Study Locations (1)

Missouri

  • Washington University - St Louis

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2015-12-02
Est. Completion 2023-09-19
Phase NA

Sponsor

RTI Surgical

12 total trials

What the Registry Record Tells You About NCT02587403

The ClinicalTrials.gov registry entry for NCT02587403 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 136-participant average among 18 other Ventral Hernia trials with a reported enrollment target (12% lower). The listed sponsor is RTI Surgical, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ventral Hernia appearing as the primary indexed condition, and to 2 interventions - of which Fortiva™ Porcine Dermis is the first listed.

NCT02587403 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT02587403 about?

NCT02587403 is a clinical study titled "A Comparison of Fortiva and Strattice Tissue Matrices in Complex, Ventral Hernia Repair". The objective of this study is to compare the effectiveness of Fortiva Porcine Dermis versus Strattice Reconstructive Tissue Matrix for the underlay reinforcement of complex ventral hernia repair and assess post-operative complication rates, long term hernia recurrence rates.

What is the current status of trial NCT02587403?

This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2015-12-02. Estimated completion is 2023-09-19.

What conditions does trial NCT02587403 study?

This clinical trial studies the following conditions: Ventral Hernia.

What interventions are being tested in trial NCT02587403?

The interventions under investigation include: Fortiva™ Porcine Dermis (DEVICE), Strattice™ Reconstructive Tissue Matrix (DEVICE).

Who is sponsoring clinical trial NCT02587403?

This trial is sponsored by RTI Surgical, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02587403 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ventral Hernia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.